Mitiglinide Calcium
Mitiglinide Calcium (KAD-1229) is a rapid-acting insulin secretagogue that functions by blocking ATP-sensitive potassium channels in pancreatic β-cells. It is a valuable research tool for studying glucose homeostasis and insulin secretion mechanisms in both in vitro cellular assays and in vivo models of type 2 diabetes.
Product Specifications
CAS Number
145525-41-3
Product Name Alternative
Inhibit, KAD 1229, KAD1229, KAD-1229, KcsA, Mitiglinide, Mitiglinide Calcium, insulinotropic, Inhibitor, hypoglycaemic, diabetes, ATP-sensitive K+ channels, anti-diabetic, S-21403, S21403, S 21403, Potassium Channel, PotassiumChannel, type
Field of Research
Pharmacology & Drug Discovery
Purity
99.54% (May vary between batches)
Solubility
DMSO:5 mg/mL (7.48 mM)
Smiles
[CaH2].OC (=O) [C@H] (CC (=O) N1C[C@H]2CCCC[C@H]2C1) Cc1ccccc1
Molecular Formula
(C19H24NO3) 2·Ca
Molecular Weight
668.88
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0246106 1.0 µg DNA
C6orf106 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 